|
1
|
González-Chávez SA, Arévalo-Gallegos S and
Rascón-Cruz Q: Lactoferrin: structure, function and applications.
Int J Antimicrob Agents. 33:301.e1–e.8. 2009.
|
|
2
|
Steijns JM and van Hooijdonk AC:
Occurrence, structure, biochemical properties and technological
characteristics of lactoferrin. Br J Nutr. 84(Suppl 1): S11–S17.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
van der Strate BW, Beljaars L, Molema G,
Harmsen MC and Meijer DK: Antiviral activities of lactoferrin.
Antiviral Res. 52:225–239. 2001.
|
|
4
|
Öztaş Yeşim ER and Özgüneş N: Lactoferrin:
a multifunctional protein. Adv Mol Med. 1:149–154. 2005.
|
|
5
|
Pierce A, Legrand D and Mazurier J:
Lactoferrin: a multifunctional protein. Med Sci. 25:361–369.
2009.
|
|
6
|
de Mejia EG and Dia VP: The role of
nutraceutical proteins and peptides in apoptosis, angiogenesis, and
metastasis of cancer cells. Cancer Metastasis Rev. 29:511–528.
2010.PubMed/NCBI
|
|
7
|
Mason DY and Taylor CR: Distribution of
transferrin, ferritin, and lactoferrin in human tissues. J Clin
Pathol. 31:316–327. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Reitamo S, Konttinen YT, Dodd S and
Adinolfi M: Distribution of lactoferrin in human fetal tissues.
Acta Paediatr Scand. 70:395–398. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ieni A, Barresi V, Grosso M and Tuccari G:
Immunohistochemical evidence of lactoferrin in human embryo-fetal
bone and cartilage tissues. Cell Biol Int. 34:845–849. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cornish J: Lactoferrin promotes bone
growth. Biometals. 17:331–335. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Naot D, Grey A, Reid IR and Cornish J:
Lactoferrin a novel bone growth factor. Clin Med Res. 3:93–101.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cornish J and Naot D: Lactoferrin as an
effector molecule in the skeleton. Biometals. 23:425–430. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ieni A, Barresi V, Grosso M, Rosa MA and
Tuccari G: Lactoferrin immuno-expression in human normal and
neoplastic bone tissue. J Bone Miner Metab. 27:364–371. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ieni A, Barresi V, Grosso M, Rosa MA and
Tuccari G: Immunolocalization of lactoferrin in cartilage-forming
neoplasms. J Orthop Sci. 14:732–737. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ieni A, Barresi V, Grosso M, Speciale G,
Rosa MA and Tuccari G: Does lactoferrin behave as an
immunohistochemical oncofetal marker in bone and cartilage human
neoplasms? Pathol Oncol Res. 17:287–293. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tuccari G, Villari D, Giuffrè G, Simone A,
Squadrito G, Raimondo G and Barresi G: Immunohistochemical evidence
of lactoferrin in hepatic biopsies of patients with viral or
cryptogenetic chronic liver disease. Histol Histopathol.
17:1077–1083. 2002.PubMed/NCBI
|
|
17
|
Blais A, Malet A, Mikogami T, Martin-Rouas
C and Tomé D: Oral bovine lactoferrin improves bone status of
ovariectomized mice. Am J Physiol Endocrinol Metab. 296:1281–1288.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guo HY, Jiang L, Ibrahim SA, Zhang L,
Zhang H, Zhang M and Ren FZ: Orally administered lactoferrin
preserves bone mass and microarchitecture in ovariectomized rats. J
Nutr. 139:958–964. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Takayama Y and Mizumachi K: Effect of
lactoferrin-embedded collagen membrane on osteogenic
differentiation of human osteoblast-like cells. J Biosci Bioeng.
107:191–195. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Naot D, Chhana A, Matthews BG, Callon KE,
Tong PC, Lin JM, Costa JL, Watson M, Grey AB and Cornish J:
Molecular mechanisms involved in the mitogenic effect of
lactoferrin in osteoblasts. Bone. 49:217–224. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tuccari G and Barresi G: Lactoferrin in
human tumours: immunohistochemical investigations during more than
25 years. Biometals. 24:775–784. 2011.PubMed/NCBI
|
|
22
|
Penco S, Scarfì S and Giovine M:
Identification of an import signal for, and the nuclear
localization of, human lactoferrin. Biotechnol Appl Biochem.
34:151–159. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Barresi G and Tuccari G: Lactoferrin in
benign hypertrophy and carcinomas of the prostatic gland. Virchows
Arch A Pathol Anat Histopathol. 403:59–66. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tuccari G, Rizzo A, Crisafulli C and
Barresi G: Iron-binding proteins in human colorectal adenomas and
carcinomas: an immunocytochemical investigation. Histol
Histopathol. 7:543–547. 1992.PubMed/NCBI
|
|
25
|
Giuffrè G, Arena F, Scarfì R, Simone A,
Todaro P and Tuccari G: Lactoferrin immunoexpression in endometrial
carcinomas: relationships with sex steroid hormone receptors (ER
and PR), proliferation indices (Ki-67 and AgNOR) and survival.
Oncol Rep. 16:257–263. 2006.PubMed/NCBI
|
|
26
|
Giuffrè G, Barresi V, Skliros C, Barresi G
and Tuccari G: Immunoexpression of lactoferrin in human sporadic
renal cell carcinomas. Oncol Rep. 17:1021–1026. 2007.PubMed/NCBI
|
|
27
|
Wurster K, Heberling D and Rapp W:
Carcinoembryogenic antigen (CEA) and lactoferrin (LF) in benign and
malignant disease of the breast. A contribution to the
immuno-histological demonstration of marker substances.
Geburtshilfe Frauenheilkd. 40:412–422. 1980.(In German).
|
|
28
|
Charpin C, Lachard A, Pourreau-Schneider
N, et al: Localization of lactoferrin and nonspecific
cross-reacting antigen in human breast carcinomas. An
immunohistochemical study using the avidin-biotin-peroxidase
complex method. Cancer. 55:2612–2617. 1985. View Article : Google Scholar
|
|
29
|
Wrba F, Reiner A, Markis-Ritzinger E,
Holzner JH, Reiner G and Spona J: Prognostic significance of
immunohistochemical parameters in breast carcinomas. Pathol Res
Pract. 183:277–283. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Caselitz J, Jaup T and Seifert G:
Lactoferrin and lysozyme in carcinomas of the parotid gland.
Virchows Arch A Pathol Anat Histol. 394:61–73. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cabaret V, Vilain MO, Delobelle-Deroide A
and Vanseymortier L: Immunohistochemical demonstration of
ceruloplasmin and lactoferrin in a series of 59 thyroid tumors. Ann
Pathol. 12:347–352. 1992.(In French).
|
|
32
|
Weinberg ED: Iron withholding: a defense
against infection and neoplasia. Physiol Rev. 64:65–102.
1984.PubMed/NCBI
|
|
33
|
Ye XY, Wang HX, Liu F and Ng TB:
Ribonuclease, cell-free translation-inhibitory and superoxide
radical scavenging activities of the iron-binding protein
lactoferrin from bovine milk. Int J Biochem Cell Biol. 32:235–241.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tuccari G, Rossiello R and Barresi G: Iron
binding proteins in gallbladder carcinomas. An immunocytochemical
investigation. Histol Histopathol. 12:671–676. 1997.PubMed/NCBI
|
|
35
|
Tuccari G, Giuffrè G, Scarf R, Simone A,
Todaro P and Barresi G: Immunolocalization of lactoferrin in
surgically resected pigmented skin lesions. Eur J Histochem.
49:33–38. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Roiron D, Amouric M, Marvaldi J and
Figarella C: Lactoferrin-binding sites at the syurface of HT29-D4
cells. Comparison with transferrin. Eur J Biochem. 186:367–373.
1989. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Suzuki YA, Lopez V and Lönnerdal B:
Mammalian lactoferrin receptors: structure and function. Cell Mol
Life Sci. 62:2560–2575. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ward PP, Paz E and Conneely OM:
Multifunctional roles of lactoferrin: a critical overview. Cell Mol
Life Sci. 62:2540–2548. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Rodrigues L, Teixeira J, Schmitt F,
Paulsson M and Månsson HL: Lactoferrin and cancer disease
prevention. Crit Rev Food Sci Nutr. 49:203–217. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fujita K, Matsuda E, Sekine K, Iigo M and
Tsuda H: Lactoferrin enhances Fas expression and apoptosis in the
colon muciosa of azoxymethane-treated rats. Carcinogenesis.
25:1961–1966. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Norrby K: Human apo-lactoferrin enhances
angiogenesis mediated by vascular endothelial growth factor A in
vivo. J Vasc Res. 41:293–304. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Shimamura M, Yamamoto Y, Ashino H, Oikawa
T, Hazato T, Tsuda H and Iigo M: Bovine lactoferrin inhibits tumor
induced angiogenesis. Int J Cancer. 111:111–116. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Damiens E, El Yazidi I, Mazurier J, et al:
Lactoferrin inhibits G1 cyclin-dependent kinases during growth
arrest of human breast carcinoma cells. J Cell Biochem. 74:486–498.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Xiao Y, Monitto CL, Minhas KM and
Sidransky D: Lactoferrin down-regulates G1 cyclin-dependent kinases
during growth arrest of head and neck cancer cells. Clin Cancer
Res. 10:8683–8686. 2004. View Article : Google Scholar : PubMed/NCBI
|
